Dr Krishna Prasad Chigurupati

Granules India’s Unit V facility in Visakhapatnam completes US FDA inspection with Zero 483 Observations 

The facility manufactures APIs & formulations of oncology and non-oncology products  Granules India announced that the Company’s Unit V facility…